Latest Recombinant proteins Stories
Novo Nordisk enters seventh year of partnership with Charlie Kimball to continue diabetes education and awareness with award-winning Race with Insulin® campaign PLAINSBORO, N.J.
Twice-Weekly Prophylactic Regimen Resulted in 95% Reduction in Median Annualized Bleed Rate Compared to On-Demand Treatment SAN FRANCISCO, Dec.
The proper regulation of body size is of fundamental importance, but the mechanisms that stop growth are still unclear.
ReportsnReports.com announces new report “2014 Market Research Report on Global Insulin Industry” added to its research database. Dallas, Texas (PRWEB) November
LONDON and BOSTON, November 20, 2014 /PRNewswire/ -- Project to develop first-in-class selective and orally available GLP-1 receptor antagonist for treating severe
DALLAS, November 19, 2014 /PRNewswire/ -- RnRMarketResearch.com adds China Recombinant Protein Drug Industry Report, 2014-2017 market research that says during 2005-2013,
The key factors that are expected to spur the growth of this market are the rising global diabetic population, favorable reimbursement scenario in North America and Europe.
Surveyed German Nephrologists Report that the Majority of Their Patients Treated with Epoetin Alfa Receive a Biosimilar, According to Findings from Decision Resources Group BURLINGTON, Mass.,
- A member of the swell-mob; a genteelly clad pickpocket. Sometimes mobsman.